Molecular mechanism underlies anxiety, autism

June 19, 2017 by Joseph Bonner
The top image shows the movement of a mouse in a behavioral test that measures social interaction. The blue to green color represents least to most time spent interacting with another mouse. The bottom set of images measures anxiety-like behavior exhibited by a mouse. The amount of filling in the vertical bars represents levels of anxiety. Credit: Dr. Zeeba Kabir/Weill Cornell Medicine

A calcium-dependent molecular mechanism discovered in the brain cells of mice by Weill Cornell Medicine investigators may underlie the impaired social interactions and anxiety found in neuropsychiatric disorders – including schizophrenia and autism.

The study, published June 6 in Molecular Psychiatry, reports that reduced function of a calcium channel at synapses, the site of contact essential for communication between neurons, impairs social behavior and heightens anxiety. The findings also illuminate how this occurs: overactivation of a molecule within protrusions in neurons, called spines, which receive communicating signals from adjacent neurons. Blocking the action of this molecule in adult mice repaired the abnormal social interactions and elevated anxiety, a finding that may lead to the development of new treatments for patients with certain neuropsychiatric and anxiety disorders.

"Our study suggests that if we can repair malfunctioning synapses in humans, we can reverse behavioral abnormalities and potentially treat specific symptoms, such as social impairment and anxiety, in patients with these neuropsychiatric disorders," said senior study author Anjali Rajadhyaksha, associate professor of neuroscience in pediatrics and of neuroscience in the Feil Family Brain and Mind Research Institute, and director of the Weill Cornell Autism Research Program at Weill Cornell Medicine. "We believe that targeting this molecule and its pathway may provide us with a molecular framework for future exploration of treatment of patients."

Rajadhyaksha and her colleagues focused on a gene called CACNA1C that has emerged as a significant risk gene across major forms of neuropsychiatric disorders: schizophrenia, bipolar disorder, major depressive disorder, and attention deficit hyperactivity disorder. Impaired and elevated anxiety are common symptoms observed in patients with these disorders.

Studies using mice lacking CACNA1C production in neurons in a part of the brain, called the prefrontal cortex, which is responsible for cognition, personality and decision-making, made mice less social and more anxious. This finding seemingly confirms those of human studies, which suggests that defects in protein production may underlie the symptoms of patients with and autism.

The investigators then identified the culprit for the social impairments and elevated anxiety: increased activity of a molecule called eIF2alpha that has been linked to cognitive deficits in neurodegenerative disorders like Alzheimer's disease.

Zeeba Kabir, the study's first author and a postdoctoral researcher in Rajadhyaksha's lab, tested a small molecule called ISRIB, which had previously been shown to block the action of eIF2alpha and improve learning and memory in mice, in rodents missing the CACNA1C gene. ISRIB reversed the aberrant behavior found in these mice, improving their social interactions and reducing anxiety.

"Some studies have revealed that ISRIB has side effects that may be harmful to human cells," Rajadhyaksha said, "but research shows that there are two alternative small molecule inhibitors of eIF2alpha that may be safer for use in humans. A next step is to study these ISRIB alternatives in to determine whether they have a similar effect."

"Neuropsychiatric disorders are complex and treatments remain suboptimal," Rajadhyaksha said. "To be able to treat specific symptoms that are common across multiple is an exciting possibility. We would also like to determine whether alterations in the eIF2alpha pathway are held in common among other rodent models displaying social deficits and that result from risk genes other than CACNA1C. If so, like ISRIB could be widely applicable for treating these symptoms, in general."

Explore further: Study may explain gene's role in major psychiatric disorders

Related Stories

Study may explain gene's role in major psychiatric disorders

April 26, 2016
A new study shows the death of newborn brain cells may be linked to a genetic risk factor for five major psychiatric diseases, and at the same time shows a compound currently being developed for use in humans may have therapeutic ...

Researchers disentangle relationship between autism spectrum disorder, anxiety, and ADHD in children

April 18, 2017
Children with autism spectrum disorder (ASD) experience internalizing and externalizing problems at higher rates than typically developing children, which could worsen social impairment, according to researchers with the ...

Aggressive flies: A powerful new model for neuropsychiatric disorders

June 7, 2017
Alterations in social behaviour, including aggression, are associated with a number of neuropsychiatric disorders such as schizophrenia and bipolar disorder. Along with DiGeorge syndrome and velo-cardio-facial syndrome, these ...

Mouse model points to potential drug target for increasing social interaction in autism

September 8, 2016
A study of a new mouse model identifies a drug target that has the potential to increase social interaction in individuals with some forms of autism spectrum disorder (ASD), according to researchers in the Perelman School ...

Mouse study suggests autism is not just a disease of the brain

June 9, 2016
Autism spectrum disorders (ASDs) are characterized by impaired social interactions and repetitive behaviors, often accompanied by abnormal reactions to sensory stimuli. ASD is generally thought to be caused by deficits in ...

A common medication restores social deficits in autism mouse model

January 26, 2017
Reducing the function of the autism-associated gene Pcdh10 leads to impairments in social behavior, according to a study published in Biological Psychiatry. Reducing Pcdh10 function also disrupted the structure and function ...

Recommended for you

Probing how Americans think about mental life

October 20, 2017
When Stanford researchers asked people to think about the sensations and emotions of inanimate or non-human entities, they got a glimpse into how those people think about mental life.

Itsy bitsy spider: Fear of spiders and snakes is deeply embedded in us

October 19, 2017
Snakes and spiders evoke fear and disgust in many people, even in developed countries where hardly anybody comes into contact with them. Until now, there has been debate about whether this aversion is innate or learnt. Scientists ...

Dutch courage—Alcohol improves foreign language skills

October 18, 2017
A new study published in the Journal of Psychopharmacology, conducted by researchers from the University of Liverpool, Maastricht University and King's College London, shows that bilingual speakers' ability to speak a second ...

Inflamed support cells appear to contribute to some kinds of autism

October 18, 2017
Modeling the interplay between neurons and astrocytes derived from children with Autism Spectrum Disorder (ASD), researchers at University of California San Diego School of Medicine, with colleagues in Brazil, say innate ...

Study suggests psychedelic drugs could reduce criminal behavior

October 18, 2017
Classic psychedelics such as psilocybin (often called magic mushrooms), LSD and mescaline (found in peyote) are associated with a decreased likelihood of antisocial criminal behavior, according to new research from investigators ...

Taking probiotics may reduce postnatal depression

October 18, 2017
Researchers from the University of Auckland and Otago have found evidence that a probiotic given in pregnancy can help prevent or treat symptoms of postnatal depression and anxiety.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

BubbaNicholson
1 / 5 (1) Jun 20, 2017
The symptoms of ADHD, attention deficit hyperactivity disorder, can be alleviated by taking by mouth 10 mg of healthy adult male facial skin surface lipid pheromone, with a cure possible if intake of the pheromone reaches 250mg. Shared structures mean the other illnesses mentioned should be approachable, too, likely with the same pheromone.
Take extreme care with the liquid skin surface "face grease" pheromone, since vapors from it cause distrust, suspicion, jealousy, arrogance, and stupidity. Freeze the pheromone once collected, keep it under barrier bags with activated charcoal dunnage. Use oscillating fans, staff to wear supplied air ventilators. Isolate treated patients for 40 days.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.